B-CELL CHANGES ASSOCIATED WITH HIV-1 THROMBOCYTOPENIA
B-CELL CHANGES ASSOCIATED WITH HIV-1 THROMBOCYTOPENIA
批准号:
2518487
负责人:
ROSS S BASCH
金额:
$29.72万
依托单位国家:
美国
项目类别:
财政年份:
1994
资助国家:
美国
项目状态:
已结题
起止时间:
1994-09-30 至 2000-08-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (Adapted from the applicant's abstract)
The applicants have demonstrated an unusual association of apparently
unrelated hematological abnormalities in a group of HIV-l infected
individuals. HIV-l seropositive, thrombocytopenic individuals showed
marked alterations in their B-cell subsets. Although B-cell numbers were
normal, both the proportion of CD5+ cells and their absolute number were
increased and the absolute number of CD5- B-cells were markedly reduced.
In some patients 90 percent of the circulating B-cells were CD5+
(normal=18.2 + 2.3%). The alteration in the B-cell subsets was neither
attributable to changes in CD4 or CD8 cell number, CD4/CD8 ratio, or
absolute lymphocyte count nor to severity of disease nor to AZT
treatment.
The applicants suggest that it is improbable that the association of
thrombocytopenia and aberrant B-cell profile occurred through
happenstance. Their proposal is designed to investigate the basis of the
association. Three possible explanations will be examined: (1) Both
the abnormalities could be consequences of an autoimmune response,
associated with the prevalence of CD5+ B cells, and directed against
either the mature cells or their progenitors in the marrow. Sera from
infected patients will be assayed for autoantibodies reactive with B
cells and platelets or their progenitors. The applicants will also seek
cell-bound autoantibodies or immune complexes similar to those found on
platelets of patients with HIV-1 + ITP. If anti-B-cell antibodies are
found, they will determine how CD5+ B-cells escape this autoimmune
response. (2) The abnormalities could be a direct effect of HIV-l
infection on either a hematopoietic precursor or a cell necessary for
the development of B-cells and megakaryocytes. Both long term bone
marrow cell cultures and short-term clonal cultures will be used to
study the effects of virus, HIV-l infected cells and serum on the
development of B-cells. (3) The changes in lympho-hematopoiesis could be
a result of dysregulation induced by either the deficiency of CD4+ T-
cells or the excess of CD8+ T-cells. T-cell derived cytokines are known
to have profound effects on both MK and B-cell development. The relative
T-independence of the CD5+ subset may account for their persistence.
This possibility will be examined using two model systems. In the first,
selected populations of human cells from uninfected subjects will be
transferred to immunodeficient (SCID) mice. Cell sorting will be used
to isolate highly enriched populations of CD5+ and CD5- B-cells, or their
precursors as well as T-cell populations expressing either CD4 or CD8.
Various combinations of these populations will be injected and the
survival of the B-cell subsets determined. In the second model, an
attempt will be made to reproduce the phenomenon in a totally murine
system. Again, cells of the necessary phenotypes will be prepared by
cell sorting and injected into SCID mice, but in this model only cells
from syngeneic mice will be transferred, eliminating the possibility
that problems of histo-incompatibility will confound the developmental
studies.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1210/endo.139.9.6209
发表时间:
1998-09
期刊:
Endocrinology
影响因子:
4.8
作者:
[Richard W. Steger;V. Chandrashekar;W. Zhao;A. Bartke;N. Horseman]
通讯作者:
Richard W. Steger;V. Chandrashekar;W. Zhao;A. Bartke;N. Horseman
C21, a Transcriptional Regulator in Hematopoiesis
-
批准号:6546959
-
项目类别:
-
资助金额:$37.91万
-
财政年份:2002
-
负责人:ROSS S BASCH
-
依托单位:
C21, a Transcriptional Regulator in Hematopoiesis
-
批准号:6667252
-
项目类别:
-
资助金额:$38.03万
-
财政年份:2002
-
负责人:ROSS S BASCH
-
依托单位:
C21, a Transcriptional Regulator in Hematopoiesis
-
批准号:6794696
-
项目类别:
-
资助金额:$38.03万
-
财政年份:2002
-
负责人:ROSS S BASCH
-
依托单位:
C21, a Transcriptional Regulator in Hematopoiesis
-
批准号:6943047
-
项目类别:
-
资助金额:$38.03万
-
财政年份:2002
-
负责人:ROSS S BASCH
-
依托单位:
CORE--FLOW CYTOMETRY FACILITY
-
批准号:6315258
-
项目类别:
-
资助金额:$13.42万
-
财政年份:2000
-
负责人:ROSS S BASCH
-
依托单位:
CORE--FLOW CYTOMETRY FACILITY
-
批准号:6101771
-
项目类别:
-
资助金额:$13.42万
-
财政年份:1999
-
负责人:ROSS S BASCH
-
依托单位:
CORE--CELL SORTING UNIT
-
批准号:6268905
-
项目类别:
-
资助金额:$18.77万
-
财政年份:1997
-
负责人:ROSS S BASCH
-
依托单位:
CORE--CELL SORTING UNIT
-
批准号:6236310
-
项目类别:
-
资助金额:$19.05万
-
财政年份:1996
-
负责人:ROSS S BASCH
-
依托单位:
HEMATOPOIETIC PRECURSORS
-
批准号:2142966
-
项目类别:
-
资助金额:$19.01万
-
财政年份:1994
-
负责人:ROSS S BASCH
-
依托单位:
B-CELL CHANGES ASSOCIATED WITH HIV-1 THROMBOCYTOPENIA
-
批准号:2150853
-
项目类别:
-
资助金额:$22.34万
-
财政年份:1994
-
负责人:ROSS S BASCH
-
依托单位:
B-CELL CHANGES ASSOCIATED WITH HIV-1 THROMBOCYTOPENIA
-
批准号:2150854
-
项目类别:
-
资助金额:$28.18万
-
财政年份:1994
-
负责人:ROSS S BASCH
-
依托单位:
HEMATOPOIETIC PRECURSORS
-
批准号:2142969
-
项目类别:
-
资助金额:$20.28万
-
财政年份:1994
-
负责人:ROSS S BASCH
-
依托单位:
HEMATOPOIETIC PRECURSORS
-
批准号:2142968
-
项目类别:
-
资助金额:$19.76万
-
财政年份:1994
-
负责人:ROSS S BASCH
-
依托单位:
B-CELL CHANGES ASSOCIATED WITH HIV-1 THROMBOCYTOPENIA
-
批准号:2017001
-
项目类别:
-
资助金额:$28.93万
-
财政年份:1994
-
负责人:ROSS S BASCH
-
依托单位:
SHARED FLOW CYTOMETRY FACILITY (FACSTAR PLUS)
-
批准号:3521299
-
项目类别:
-
资助金额:$26.3万
-
财政年份:1991
-
负责人:ROSS S BASCH
-
依托单位:
STRUCTURE AND FUNCTION OF MARKERS OF THE IMMUNE SYSTEM
-
批准号:3091696
-
项目类别:
-
资助金额:$60.74万
-
财政年份:1986
-
负责人:ROSS S BASCH
-
依托单位:
STRUCTURE AND FUNCTION OF MARKERS OF THE IMMUNE SYSTEM
-
批准号:3091694
-
项目类别:
-
资助金额:$51.46万
-
财政年份:1986
-
负责人:ROSS S BASCH
-
依托单位:
STRUCTURE AND FUNCTION OF MARKERS OF THE IMMUNE SYSTEM
-
批准号:3091697
-
项目类别:
-
资助金额:$59.11万
-
财政年份:1986
-
负责人:ROSS S BASCH
-
依托单位:
SOMATIC CELL GENETICS OF T-CELL DIFFERENTIATION ANTIGENS
-
批准号:3171055
-
项目类别:
-
资助金额:$9.46万
-
财政年份:1982
-
负责人:ROSS S BASCH
-
依托单位:
SOMATIC CELL GENETICS OF T-CELL DIFFERENTIATION ANTIGENS
-
批准号:3171057
-
项目类别:
-
资助金额:$11.86万
-
财政年份:1982
-
负责人:ROSS S BASCH
-
依托单位:
海外基金